Literature DB >> 23524658

Non-invasive optical imaging of the lymphatic vasculature of a mouse.

Holly A Robinson1, SunKuk Kwon, Mary A Hall, John C Rasmussen, Melissa B Aldrich, Eva M Sevick-Muraca.   

Abstract

The lymphatic vascular system is an important component of the circulatory system that maintains fluid homeostasis, provides immune surveillance, and mediates fat absorption in the gut. Yet despite its critical function, there is comparatively little understanding of how the lymphatic system adapts to serve these functions in health and disease. Recently, we have demonstrated the ability to dynamically image lymphatic architecture and lymph "pumping" action in normal human subjects as well as in persons suffering lymphatic dysfunction using trace administration of a near-infrared fluorescent (NIRF) dye and a custom, Gen III-intensified imaging system. NIRF imaging showed dramatic changes in lymphatic architecture and function with human disease. It remains unclear how these changes occur and new animal models are being developed to elucidate their genetic and molecular basis. In this protocol, we present NIRF lymphatic, small animal imaging using indocyanine green (ICG), a dye that has been used for 50 years in humans, and a NIRF dye-labeled cyclic albumin binding domain (cABD-IRDye800) peptide that preferentially binds mouse and human albumin. Approximately 5.5 times brighter than ICG, cABD-IRDye800 has a similar lymphatic clearance profile and can be injected in smaller doses than ICG to achieve sufficient NIRF signals for imaging. Because both cABD-IRDye800 and ICG bind to albumin in the interstitial space, they both may depict active protein transport into and within the lymphatics. Intradermal (ID) injections (5-50 μl) of ICG (645 μM) or cABD-IRDye800 (200 μM) in saline are administered to the dorsal aspect of each hind paw and/or the left and right side of the base of the tail of an isoflurane-anesthetized mouse. The resulting dye concentration in the animal is 83-1,250 μg/kg for ICG or 113-1,700 μg/kg for cABD-IRDye800. Immediately following injections, functional lymphatic imaging is conducted for up to 1 hr using a customized, small animal NIRF imaging system. Whole animal spatial resolution can depict fluorescent lymphatic vessels of 100 microns or less, and images of structures up to 3 cm in depth can be acquired. Images are acquired using V++ software and analyzed using ImageJ or MATLAB software. During analysis, consecutive regions of interest (ROIs) encompassing the entire vessel diameter are drawn along a given lymph vessel. The dimensions for each ROI are kept constant for a given vessel and NIRF intensity is measured for each ROI to quantitatively assess "packets" of lymph moving through vessels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524658      PMCID: PMC3622105          DOI: 10.3791/4326

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening.

Authors:  Ekaterina I Galanzha; Valery V Tuchin; Vladimir P Zharov
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Near-infrared fluorescence imaging of lymphatics in head and neck lymphedema.

Authors:  Erik A Maus; I-Chih Tan; John C Rasmussen; Milton V Marshall; Caroline E Fife; Latisha A Smith; Renie Guilliod; Eva M Sevick-Muraca
Journal:  Head Neck       Date:  2010-11-12       Impact factor: 3.147

4.  Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Authors:  Cynthia A Davies-Venn; Bonnie Angermiller; Nathaniel Wilganowski; Pradip Ghosh; Barrett R Harvey; Grace Wu; Sunkuk Kwon; Melissa B Aldrich; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

5.  Imaging prostate cancer lymph node metastases with a multimodality contrast agent.

Authors:  Mary A Hall; Sunkuk Kwon; Holly Robinson; Pier-Anne Lachance; Ali Azhdarinia; Ranjani Ranganathan; Roger E Price; Wenyaw Chan; Eva M Sevick-Muraca
Journal:  Prostate       Date:  2011-05-02       Impact factor: 4.104

6.  Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging.

Authors:  I-Chih Tan; Erik A Maus; John C Rasmussen; Milton V Marshall; Kristen E Adams; Caroline E Fife; Latisha A Smith; Wenyaw Chan; Eva M Sevick-Muraca
Journal:  Arch Phys Med Rehabil       Date:  2011-05       Impact factor: 3.966

7.  RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice.

Authors:  Philip E Lapinski; Sunkuk Kwon; Beth A Lubeck; John E Wilkinson; R Sathish Srinivasan; Eva Sevick-Muraca; Philip D King
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

8.  Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence.

Authors:  John C Rasmussen; I-Chih Tan; Milton V Marshall; Kristen E Adams; Sunkuk Kwon; Caroline E Fife; Erik A Maus; Latisha A Smith; Kyle R Covington; Eva M Sevick-Muraca
Journal:  Transl Oncol       Date:  2010-12-01       Impact factor: 4.243

Review 9.  Lymphatic imaging in humans with near-infrared fluorescence.

Authors:  John C Rasmussen; I-Chih Tan; Milton V Marshall; Caroline E Fife; Eva M Sevick-Muraca
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

10.  Noninvasive quantitative imaging of lymph function in mice.

Authors:  Sunkuk Kwon; Eva M Sevick-Muraca
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

View more
  14 in total

1.  Nodal lymph flow quantified with afferent vessel input function allows differentiation between normal and cancer-bearing nodes.

Authors:  Alisha V DSouza; Jonathan T Elliott; Jason R Gunn; Richard J Barth; Kimberley S Samkoe; Kenneth M Tichauer; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2015-03-17       Impact factor: 3.732

Review 2.  Imaging the lymphatic system.

Authors:  Lance L Munn; Timothy P Padera
Journal:  Microvasc Res       Date:  2014-06-21       Impact factor: 3.514

3.  T helper 2 differentiation is necessary for development of lymphedema.

Authors:  Catherine L Ly; Gabriela D García Nores; Raghu P Kataru; Babak J Mehrara
Journal:  Transl Res       Date:  2018-12-21       Impact factor: 7.012

4.  Lymphatic function measurements influenced by contrast agent volume and body position.

Authors:  Echoe M Bouta; Cedric Blatter; Thomas A Ruggieri; Eelco Fj Meijer; Lance L Munn; Benjamin J Vakoc; Timothy P Padera
Journal:  JCI Insight       Date:  2018-01-25

Review 5.  Experimental Models Used to Assess Lymphatic Contractile Function.

Authors:  Scott D Zawieja; Jorge A Castorena-Gonzalez; Brandon Dixon; Michael J Davis
Journal:  Lymphat Res Biol       Date:  2017-12       Impact factor: 2.589

6.  Method for the quantitative measurement of collecting lymphatic vessel contraction in mice.

Authors:  Shan Liao; Dennis Jones; Gang Cheng; Timothy P Padera
Journal:  J Biol Methods       Date:  2014

Review 7.  Lymphangiogenesis and Lymphatic Barrier Dysfunction in Renal Fibrosis.

Authors:  Jing Liu; Chen Yu
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

8.  Obesity-induced lymphatic dysfunction is reversible with weight loss.

Authors:  Matthew D Nitti; Geoffrey E Hespe; Raghu P Kataru; Gabriela D García Nores; Ira L Savetsky; Jeremy S Torrisi; Jason C Gardenier; Andrew J Dannenberg; Babak J Mehrara
Journal:  J Physiol       Date:  2016-10-09       Impact factor: 5.182

Review 9.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

10.  Lymphatic vascular response to acute inflammation.

Authors:  Pier-Anne Lachance; Amy Hazen; Eva M Sevick-Muraca
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.